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Summary
In traditional medicine, herbs with antioxidant properties have been used to treat vari-
ous conditions. Promising results of antioxidant capacity, may suggest that further in-
vestigations might lead to development of new prophylactic and therapeutic drugs for a
numerous of oxidative diseases.
The aim of this master thesis is to evaluate some of the antioxidant properties of Her-
niaria incana Lam.. This is the first time the plant is being investigated with respect to
potential antioxidant effect, but several of its close relatives have been used in traditional
medicine in treatment of various diseases.
The total flavonoid content and the antioxidant capacity of the methanolic extract of H.
incana, were determined using UV-VIS spectroscopy by the aluminum nitrate method,
the Folin-Ciocalteu reducing capacity assay, the phosphomolybdenum assay and the 2,2-
diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay, respectively. The re-
sults are presented as the mean and the standard deviation of the parellels performed.
The total flavonoid content was estimated to be 20.46± 0.07 microgram quercetin equiv-
alents per milligram of dry weight plant extract. The Folin-Ciocalteu reducing capacity
was estimated to be 35.0 ± 1.6 microgram gallic acid equivalents per milligram of the
dry weight plant extract. The phosphomolybdenum reducing capacity was estimated to
be 0.84 ± 0.25 millimol α-tocopherol equivalents per gram of the dry weight plant ex-
tract, or 362 ± 106 microgram α-tocopherol equivalents per milligram of the dry weight
plant extract. The DPPH free radical scavenging capacity was presented as the concen-
tration of reductant necessary to decrease the initial DPPH concentration by fifty percent.
(EC50). The EC50 of H. incana was determined to 71.1 ± 8.6 µg/mL, compared to that
of 6.6 ± 1.0 µg/mL for ascorbic acid.
These preliminary investigations, showed that H. incana has a moderate content of flavonoids
and a moderate antioxidant capacity. Since these are the first results of this kind for H.
incana, they represent a contribution to better understanding of its chemical composition,
pointing the direction for future studies.
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AC Antioxidant capacity
ATE α-tocopherol equivalents
DNA Deoxyribonucleic acid
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1 Introduction
1.1 The aim of the master thesis
In the last years, there have been great focus on the possible health benefits of natural
substances with antioxidant properties. This has resulted in an enormous increase of
research on the antioxidant capacity of different plant extracts.
In traditional medicine, herbs with antioxidant properties have been used to treat vari-
ous conditions. Promising results of antioxidant capacity may suggest that further in-
vestigations might lead to development of new prophylactic and therapeutic drugs for a
numerous of oxidative diseases, such as cancer and cardiovascular diseases [1, 2].
Species of Herniaria from the plant family Caryophyllaceae, have been used in tradi-
tional medicine in treatment of various diseases such as hypertension and kidney stones
[3, 4]. The work in this master thesis is a preliminary investigation of Herniaria incana
Lam., as a part of a larger project aimed at the study of its chemical composition. The
aim of this master thesis was to evaluate some of the antioxidant properties of this plant
species. To the best of our knowledge, this is the first time the plant has been investigated
with respect to potential antioxidant effect.
There are no published data on the chemical composition of H. incana. However, other
Herniaria species have been found to contain flavonoids and saponins [5, 6, 7]. Flavonoids
are a class of secondary metabolites known for their ability to scavenge free radicals and
their strong antioxidant activity [8]. Hence, an assay determining the flavonoid content
of H. incana has been performed.
Antioxidants can act by many mechanisms. The reducing capacity is an important prop-
erty of antioxidants and it is easy to test it in vitro. Three different assays investigating the
reducing capacity of the plant extract have been performed; the Folin-Ciocalteu assay, the
phosphomolybdenum assay and the 1,1-diphenyl-2-picryl-hydrazyl (DPPH) free radical
scavenging assay. These assays are regularly used in studies investigating antioxidant
properties of plant extracts [9, 10, 11].
Saponins are a group of secondary metabolites that have shown various biological ac-
tivity such as antimicrobial activity and anticancer activity [12]. Isolation and structure
elucidation of saponins in H. incana will also be subject to the investigation of the plant
in the larger project.
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1.2 Natural substances as a source of development of new drugs
Drugs of natural origin have been classified as ”original natural products, products de-
rived semisynthetically from natural products, or synthetic products based on natural
product models [13]”.
For thousands of years natural products have been used in traditional medicine and as nat-
ural poisons [14]. Chemical investigations of such natural products have lead to the dis-
covery of important drugs such as aspirin, digitoxin, morphine, quinine and pilocarpine
[14]. The discovery of penicillin revolutionized the drug discovery research [14]. Pharma-
ceutical companies started culturing microorganisms in the search for new antibiotics, re-
sulting in drugs such as streptomycin, chloramphenicol, chlortetracycline, cephalosporin
C, erythromycin and vancomycin [14].
From the early 1980s, it was believed that the future of drug development was in com-
binatorial chemistry technology, causing the formation of libraries containing hundreds
of thousands to millions of new compounds. This resulted in a decreased interest in the
research of natural products in the pharmaceutical industry [15].
The idea was that screening of these compounds would give new lead drugs simply by the
weight of number [14]. However, it was noticed that these synthetic compounds lacked
“the complexity normally associated with bioactive natural products, items such as mul-
tiple chiral centers, heterocyclic substituents, and polycyclic structures“ [15]. Although
combinatorial chemistry has offered a great advantage in the drug development, the tech-
nology has been more useful in making moderations to lead compounds, than making
derivatives from scratch [15]. In fact, only one de novo combinatorial compound has
been approved as drug between 1981 an 2007, the kinase inhibitor Sorafenib, approved
by the Food and Drug Administration (FDA) in 2005 for renal carcinoma [15].
Cragg et. al. mentioned in 1997 that “only 5-15 % of the approximately 250 000 species
of higher plants have been systematically investigated for the presence of bioactive com-
pounds, while the potential of the marine environment has barely been tapped” [13].
Fifteen years later the number is certainly higher, but still there is an unknown potential
of compounds waiting to be discovered. Newman and Cragg have gone through all new
approved agents from 1981 to 2006. Of 155 drugs used in cancer therapy from 1940s to
2007, 73 % are drugs of natural origin and 47 % being natural products or directly derived
from a natural product. [16]. This demonstrates that natural compounds, or compounds
derived from natural products, still play an important part in discovery and development
of new drugs[14].
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1.3 Antioxidants and free radicals
An antioxidant is defined as "a molecule capable of slowing or preventing the oxidation
of other molecules" [17], or as "any substance that, when present at low concentrations
compared to those of an oxidizable substrate, significantly delays or prevents oxidation
of that substrate" [17].
A simple search for “antioxidant” or “antioxidants” on ISI Web of Science (09.05.2012),
gives 33 683 hits for the timespan 1945-2000 and 111 392 hits for the timespan 2000-
2012. This demonstrates the enormous increase in antioxidant research over the last
decade.
A free radical is a higly reactive molecule or chemical species that contains one or more
unpaired electron [18]. These unpaired electrons make the radical very reactive and cause
oxidative stress, defined as “an imbalance between oxidants and antioxidants in favor of
the oxidants, potentially leading to damage” [19].
Oxidation can harm various biological systems by damaging lipids, proteins, enzymes,
carbohydrates and deoxyribonucleic acid (DNA). This can result in membrane damage,
fragmentation or random cross linking of molecules and even lead to cell death induced
by DNA fragmentation and lipid peroxidation [19]. A relationship is reported between
oxidative damages and various diseases, such as cardiovascular diseases, cancer, liver dis-
eases, neurodegenerative disorders, aging, autoimmune diseases, diabetes and atheroscle-
rosis [1, 2].
Antioxidants are believed to be efficient prophylactic and therapeutic agents in many
oxidative diseases [19]. Several secondary metabolites from plants are proven to be good
antioxidants, e.g. phenolic acids, flavonoids and carotenoids [1] (see section 1.4).
Antioxidants have several mechanisms of action [20]:
• inhibition by generation of reactive oxygen species (ROS) or reactive nitrogen
species (RNS)
• scavenging effect
• reducing capacity
• metal chelating capacity
• activity as antioxidative enzymes
• inhibition of oxidative enzymes
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The mechanism the antioxidant act by may be dependent on the reaction system, and the
radicals or oxidant sources involved [17].
Figure 1: Classification of antioxidants as enzymatic and non-enzymatic [19].
There are two main classes of antioxidants, enzymatic and non-enzymatic, as shown in
figure 1 [19]. Examples of enzymatic antioxidants are superoxide dismutase, gluthathione
peroxidase and catalase [19, 17]. Examples of non-enzymatic are minerals, vitamins,
carotenoids, organosulphur compounds, low molecular weight antioxidants, antioxidant
cofactors and polyphenols. Vitamins, carotenoids, flavonoids and phenolic acids are ex-
amples of types of dietary antioxidants [19].
The humane antioxidant defense is equipped with enzymatic, hydrophilic and lipophilic
radical scavengers. Some of these agents are produced by the body itself, but most of
them derives from dietary sources. In medical conditions caused by oxidative stress, the
balance between oxidants and antioxidants are off, and the humane antioxidant defense
4
against ROS are weakened [19].
1.4 Secondary metabolites with antioxidant properties
Most of the plant constituents used medicinally are secondary metabolites, meaning that
they are “substances formed in plants, but not participants of the metabolic processes
which are necessary for the life and development of the plant” [21]. The composition of
secondary metabolites in plants is dependent on various factors , among others on the soil
properties, time for harvesting, and climate [22]. Typical classes of compounds known
for their antioxidant potential are isoprenoids and polyphenols [23].
Isoprenoids is a term used for groups of compounds derived from isoprene (2-metyl-
1,3-butadien) [24]. Examples of different types of isoprenoids are the terpenes (mono,
sesqui, di, and triterpenes), carotenoids and steroids. The most powerful antioxidants of
the isoprenoids are the carotenoids and the abietane diterpenes. Isoprenoids are gener-
ally more lipophilic than polypehnols. Carotenoids, like β -carotene and lycopene, are
known for their chemopreventive activities, probably contributed by an antioxidant cas-
cade [23].
Polyphenols in plants are a structural group of secondary metabolites, containing aro-
matic functional groups. They are derived from either the shikimic acid pathway, or
from the polymalonate pathway, or by a combination of these. Phenolic compounds have
been found to exhibit a variety of bioactivities, such as anti-allergic, anti-artherogenic,
anti-inflammatory, anti-microbial, antioxidant, anti-thrombotic, cardioprotective and va-
sodilatory effects [25]. Known groups of polyphenols are xanthones, stilbenes, anthraquinones,
flavonoids, lignans, neolignans, lignins and condensed tannins [25]. The flavonoids are an
important type of polyphenols that are known as great antioxidants [24]. The flavonoids
are more closely discussed in section 1.5.
Other compounds that are known for their antioxidant properties are tocopherols and
vitamin C. Tocopherols are powerful free radical scavengers. Vitamin C is essential and
needs to be in the diet of humans [19].
1.5 Flavonoids
Flavonoids are a large group of polyphenolic secondary metabolites found in ferns and
higher plants. They occur both in free state and as glycosides. Most flavonoids are yellow
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and they are present as dissolved glycosides in the cell sap of flowers, contributing to the
colours. A group of flavonoids called anthocyanidines contribute to red, blue or purple
colours in flowers, depending on the pH of the cell sap. The colours are important in
pollination for attracting seed dispersers, and in feeding on plants. Some flavonoids have
a very bitter taste, which repels caterpillars from feeding on the plant [24, 26] .
Fruits and vegetables are a giant source for human dietary flavonoids. Flavonoids are
known for their good antioxidant capacity, and they are belived to be of great health
benefits to humans. At least four thousands different compounds of flavonoids have been
isolated, and it is the largest group of naturally occuring phenols [24]. There are several
subclasses of flavonoids; chalcones, flavones, isoflavonoids, aurones, anthocyanidines,
flavanones and flavonols [24, 26].
Figure 2: Generic structure of a flavonoid [25]
1.5.1 Biosynthesis and structure
The basic structure of flavonoids are shown in figure 2, and constitutes of two aromatic
rings connected by a 3-carbon chain. In plants, aromatic rings can be formed by two
pathways; the shikimic acid pathway and the acylpoymalonate pathway. Flavonoids are
biosynthesized in a combination of these two pathways. A simple overview of the biosyn-
thesis is shown in figure 3. First the amino acid phenylalanine derived from shikimic acid
is used as a precursor to yield p-coumaric acid via cinnamic acid. P-coumaric acid acts
as a starting compound in a polyketide synthesis, and is the source for the first aromatic
ring. In the next steps three malonyl-CoA molecules are used to get three acetate residues,
which are incorporated into the structure. This is followed by ring closure, giving the sec-
ond aromatic ring. Further ring closure involving the 3-carbon chain and this hydroxyl
group can form a 6-membered or a 5-membered ring. Subsequent hydroxylation, reduc-
tions and methylations leads to the different classes of flavonoids shown in figure 4. The
addition of the sugar residues is probably one of the last reactions in the biosynthesis.
The different compounds are separated by their substituents and the position of the sugar
residues [27, 24].
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Figure 3: The biosynthesis of flavonoids. Three acetate residues are incorporated into
the polyketide starting compound, giving rise to the second aromatic ring [27].
1.5.2 Biological and pharmacological activity
The pharmacological activity of flavonoids were first described by Szent-Gyorgyi in
1938, as an ability to prevent capillary bleeding and fragility associated with scurvy.
The effect became referred to as the vitamin P activity, however the effect is not regarded
as entirely proven[24].
Later flavonoids have been reported having many pharmacological effects among others
anti-inflammatory, antihepatotoxic, antitumor, antimicrobial, antiviral, enzyme inhibit-
ing, antioxidant activity, and central vascular system effect [24]. They have also been
investigated for their inhibitory activity against human immunodeficiency virus protease
((HIV)-1 protease). Flavonols, and especially quercetin, was found to be the most potent
inhibitors of HIV-1 protease [5]. However, most of the investigations are performed in
vitro, and several of the activities are yet to be proven in in vivo assays [24].
7
Figure 4: Generic structure of the major classes of flavonoids [25]
Epidemiological studies show that flavonoids have beneficial effect in protection against
cardiovascular diseases. However, there is no correlation found between intake of flavonoids
and a reduced risk of cancer [28, 24]. ”The French paradox“, the fact that despite of
similarity in cholesterol levels and fat intake, the French have much lower incidence of
coronary heart disease than the Americans, is believed to be related to the French’s high
intake of red wine. Red wine is a good source of flavonoids, like quercetin and myricetin
[24].
There are several difficulties involved in the study of dietary flavonoids. They undergo
structural changes in the gastrointestinal tract, which makes it difficult to extrapolate re-
sults from in vitro studies to in vivo. This makes it very important to distinguish between
experiments concerned with intake of flavonoids through the orally route and experi-
ments concerned with other routes. The food itself may contain compounds interacting
with flavonoids. The effect of flavonoids seems to be mainly protective, thus it is harder
to study than effective treatment. Flavonoids have several effects, but it seems that there
is no effect for which they are solely responsible. The metabolism and pharmacokinetics
of flavonoids in humans are not very well understood, and depletion studies are difficult
to perform, since it is hard to compose a diet free of flavonoids [24].
1.6 Herniaria incana Lam.
Herniaria incana Lam. (figure 5(a)) is a flowering seed plant belonging to the Herniaria
genus in the Caryophyllaceae family, also known as the pink family [29]. It is commonly
8
known as gray rupturewort. The duration of gray rupturewort is perennial, which means
that it will grow for more than two years [29]. An overview of the classification of H.
incana is shown in table 1.
Species of Herniaria are found all over the world. Some of the more known species are
Herniaria glabra and Herniaria hirsuta, commonly known as smooth and hairy rupture-
wort, respectively [30]. Traditionally, extracts from Herniaria species were believed to
be an efficient remedy for hernia, hence the genus name [31].
“Substances, herbs or preparations are classified as drugs in Norway if they have a prop-
erty that allows them to actually prevent, treat or relieve disease, disease symptoms or
pain or affect physiological functions in humans or animals” [32]. One of H. incana’s
close relatives, Herniaria glabra (figure 5(b)), is classified as a drug in the Norwegian
list of herbs under the Norwegian name “brokkurt” [32].
Table 1: Classification of Herniaria incana Lam. [29].
Category Scientific name Common name
Kingdom Plantae Plants
Subkingdom Tracheobionta Vascular plants
Superdivision Spermatophyta Seed plants
Division Magnoliophyta Flowering plants
Class Magnoliopsida Dicotyledons
Subclass Caryophyllidae -
Order Caryophyllales -
Family Caryophyllaceae Pink family
Genus Herniaria L. Rupturewort
Species Herniaria incana Lam. Gray rupturewort
1.6.1 Traditional use
Although, there is no published data of the therapeutic use of H. incana, several other
closely related species, have been used in traditional medicine for treatment of various
conditions. Aerial parts of Herniaria fontanesii have been used in Moroccan traditional
medicine in the treatment of lithiasis and as a diuretic [6]. H. hirsuta has traditionally
been used in the treatment of kidney stones [3]. H. glabra has been used as an astringent,
diuretic and expectorant [33, 7], and aerial parts have been used in the treatment for
hypertension [4].
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(a) Herniaria incana Photo: Enzo De Santis [34]
(b) Herniaria glabra. Photo: Biopix.dk: JC Schou [35]
Figure 5: The plants (a) Herniaria incana, commonly known as gray rupturewort, and
its close relative (b) Herniaria glabra, commonly known as smooth rupturewort
1.6.2 Chemical composition
The chemical composition of H. incana is not known, although other species of Herniaria
have been found to contain flavonoids and saponins. Species from the Herniaria genus
are reported to contain polyphenolics. Stefova et. al. investigated Herniariae herba
(the aerial parts of the plant [22]) and found the flavonoid quercetin and an unidentified
flavonol [5]. Several papers have investigated the saponin content in Herniaria species,
and many new saponins have been isolated and identified [6, 7].
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1.6.3 Bioactivity
In vivo experiments have shown a diuretic and antihypertensive effect of H. glabra [33].
A study on the effect of aqueous extract from H. hirsuta L. on experimentally nephrolithi-
asic rats show beneficial effect, and confirms the benefit of using the plant as a preven-
tive agent against the formation of calcium oxalate kidney stones [3]. A variety of other
medicinal uses of H. glabra has also been reported, as the treatment of dropsy, catarrh of
the bladder, cystitis, kidney stones, gout, hernias, jaundice, nerve inflammation, respira-
tory disorders, removing excess of mucus in the stomach, to increase the flow of urine,
and in treatment of digestive and renal cancer [33].
1.7 Determination of the antioxidant capacity
In order to evaluate a plant extract‘s potential, it’s common to determine the antioxi-
dant capacity. The term antioxidant capacity expresses the ability of an antioxidant to
scavenge free radicals [36]. Several terms that describe the antioxidant capacity are be-
ing used, e.g. activity, efficiency, power, parameter, potential and potency. Some assays
report the results as the total antioxidant capacity. However, the antioxidant capacity
measured in a single assay can only reflect those specific chemical conditions in that as-
say, and it would be erroneous to generalize the data as indicators of total antioxidant
capacity[2].
No single assay available provides all necessary information. To get the best possible
impression of the overall antioxidant capacity, several assays should be applied investi-
gating different aspects of the antioxidants properties [17]. It must be emphasized that the
results from the in vitro assays based on chemical reactions, in no way can be understood
to express the in vivo activity. These assays do not measure bioactivity, in vivo stability,
retention of antioxidants by tissues and reactivity in situ [2].
Antioxidants deactivate free radicals mainly by two mechanisms; hydrogen atom transfer
(HAT) or single electron transfer (SET) [17]
1.7.1 HAT-based assays
HAT-based assays measure the ability of an antioxidant to quench free radicals by hydro-
gen donation [17]. Equation (1) show how the the antioxidant (AH) terminates the free
radical (X·) by the transfer of a hydrogen atom [17].
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X ·+AH→ XH +A· (1)
HAT reactions are usually quite rapid (gone to completion within seconds or minutes),
and they are dependent on solvent and pH. The presence of reducing agents (including
metals) influences the reaction and can lead to erroneously high apparent reactivity [17].
The quantification is usually based on kinetic curves [2].
1.7.2 SET-based assays
SET-based assays measure the ability of an antioxidant to "transfer one electron to reduce
any compound, including metals, carbonyls and radicals" [17]. Equation (2) shows that
the antioxidant losses a electron to the probe (oxidant), with the result that the antioxidant
is oxidized and the probe is reduced [2].
probe (oxidant)+ e− (from antioxidant)→ reduced probe+oxidized antioxidant (2)
The reactions are usually slow and can require a long time to complete [17]. Trace com-
pounds and contaminants, like metal ions, may interfere with the results. The indicator
of the endpoint of the reaction is the redox reaction with the oxidant.
1.7.3 Comparison of HAT- and SET-based assays
In both HAT- and SET-based assays, the radical (or oxidant) scavenging capacity is mea-
sured, instead of the preventative antioxidant capacity [2].
The hydrogen transfer in HAT-based assay is an important step in the free radical chain
reaction, suggesting that the HAT-assays are more relevant for measuring chain-breaking
antioxidant capacity. In SET-based assays the reducing capacity of the antioxidant is
measured, which is not directly related to its scavenging effect. However, the reducing
capacity is also an important property of an antioxidant [2].
The antioxidant capacity assays in this thesis are mainly SET-based.
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2 Materials
2.1 Plant material
The plant material used in this investigation origins from the location Gabrovacˇko Brdo
(Niš, Serbia, see figure 6), and was harvested and identified in June 2009 and May 2010
by Bojan Zlatkovic´ ( University of Niš, Department of Biology and Ecology, Niš, Serbia
). A voucher specimen was deposited in the Herbarium collection at the Department of
Biology and Ecology, Faculty of Science and Mathematics, University of Niš under the
acquisition number 6581.
The plant was dried for ten days at a shadowed place and then stored in a dark place
protected from light. The soil and roots were removed and the aerial parts 1 were used
for further extractions.
Figure 6: A map of Niš, Serbia: The origin of the plant material [38]
1The parts of the plant above the ground [37].
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2.2 List of chemicals
Substance Formula Purity Supplier
α-tocopherol C29H50O2 ≥ 96% (HPLC) Sigma
Aluminum nitrate nonahydrate Al(NO3)3 · 9H2O ≥ 98% Sigma-Aldrich
Ammonium molybdate (NH4)6Mo7O24 · 4H2O USP Sigma-Aldrich
Ascorbic acid C6H8O6 > 99.5% Fluka AG
1,1-diphenyl-2-picryl-hydrazyl C18H12N5O6 90% Aldrich
Ethanol CH3CH2OH > 99.8% Sigma-Aldrich
Folin-Ciocalteu reagent - - Sigma-Aldrich
Gallic acid C7H6O5 98,00% Acros Organics
n-Hexane C6H14 HPLC VWR Prolabo
Methanol CH3OH HPLC VWR Prolabo
Potassium acetate CH3COOK 90% Chemi-Teknik
Quercetin C15H10O7 ≥ 98% (HPLC) Sigma
Sodium phosphate Na3PO4 96% Aldrich
Sulfuric acid H2SO4 95-97% Merck KgaA
2.3 List of laboratory equipment
Equipment Specification Supplier
Automatic pipettes 50-200 µL, 200-1000 µL, 1-10 mL, Finnpipettes
Disposible UV-cells 2.5 mL makro Brand
Disposible UV-cells 1.5 mL semi-micro Brand
Heating bath B-490 BUCHI
Heath plate / Magnetic stirrer MR 3001 K Heidolph
Rotary evaporator Rotavapor RII BUCHI
Rotary evaporator Rotavapor R-200 BUCHI
Thermometer EKT 3001 Heidolph
Ultrasonic cleaner 3 L VWR International
UV-VIS spectrophotometer double-beam Cecil (CE9500) 9000 Series
UV-VIS spectrophotometer single-beam Shimadzu UV Mini-1240
Vacuum controller CVC2 Vaccubrand
Vacuum controller V-850 BUCHI
Vacuum pump V-700 BUCHI
Weight, analytical BL210 S Sartorius
Weight BL610 Sartorius
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3 Methods
3.1 Ultravioletvisible spectroscopy
The different assays performed in this thesis are all based on Ultraviolet–visible (UV-
VIS) spectrophotometry.
UV-VIS spectrophotometry is based on the principle that when monochromatic electro-
magnetic radiation is sendt trough a solution of an analyte, parts of the radiation will be
absorbed by the analyte, while the rest passes through. By detecting the intensity of the
radiation before and after it has passed through the sample, the absorbance of the analyte
can be measured [39]:
A = log
I0
I
(3)
Where A is the absorbance, I0 is the intensity of the radiation before absorption and I is
the intensity of the radiation after absorption. The absorbance depends on the wavelength
of the radiation, the solvent used, the pH of the sample and the temperature [39].
The Beer-Lambert law describes the relationship between the absorbance and the con-
centration of the sample [40]:
A = εlc (4)
According to Beer-Lambert’s law, the absorbance (A) is proportional to the pathlenght of
the sample cell (l), and the concentration of the sample (c) [39]. The molar absorptivity
(ε) is the characteristic of a substance that describes how much light that is absorbed
at a particular wavelength [40]. The Beer-Lambert law is applicable to dilute solutions
with a concentration below 0.01 M [40]. A higher concentration may affect the charge
distribution of the molecules and their ability to absorb radiation. This could result in a
deviation from Beer-Lamberts law [39].
Substances that absorb radiation in the same wavelength region as the test chemical,
may interfere with the absorbance [1]. The solvent must not absorb at the wavelength
of measurement [39]. The wavelengths of measurement in this thesis are 415, 517, 695
and 760 nm. The solvents used (distilled water, methanol and ethanol), do not absorb
radiation above 210 nm [39]. Most polyphenols exhibit two major absorption bands in
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(a) Absorption spectrum of chlorophyll and carotenoids
[41]
(b) Absorption spectrum of polyphenols in
finger mellet [42]
Figure 7: The asbortion spectrums for (a) chlorophyll a,b and carotenoids, and (b)
polyphenols from finger mellet.
the UV-VIS region, one band in the 320-385 nm range and the other band in the 250-285
nm range [43]. An example of the absorption spectrum of polyphenols can be seen in
figure 7(b). None of the wavelengths used in the assays coincides with the solvents or
the polyphenolic absorption bands. Chlorophyll and carotenoids strongly absorbs light
in both the 400 nm and the 600 nm region [44], and may influence the absorbance of
samples with plant extract. An example of the absorption spectrum of chlorophyl and
carotenoids can be seen in figure 7(a). Removal of chlorophyll from the plant extract has
therefore been considered as necessary.
It is important that the standards, the samples and the references are prepared in the same
way, so that the solvent, pH and possible presence of other substances, are the same
for the standard and the sample [39, 45]. “The standard curve should be set up in the
absorbance range 0.2 - 0.8 because this range offers the greatest precision“ [39].
3.2 Statistical analysis
All graphs are drawn in Gnuplot version 4.6, using the stats function for making the
linear regression lines and estimating the coefficient of determination (R2). The linear
regression equation and the value of the coefficient of determination were found to be the
same in Gnuplot and in Open Office version 3.2.0.
Open Office version 3.2.0 was used to find the probit and the standard deviation, using
the functions NORMSINV and STDEV, respectively.
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3.3 Extraction of Herniaria incana
Extraction with methanol is a commonly known method for extraction of natural sub-
stances [46, 47, 10, 48, 49, 50]. “The application of ultrasound to methanolic extrac-
tion gave a signicant reduction in extraction time and an increase in maximum yield”
[46].
Since chlorophyll absorbs light at UV regions similar to the applied wavelengths in some
of the assays (see section 3.1), removal was necessary. Chlorophyll, in addition to non-
polar compounds as carotenoids, may be removed by dissolving the dry extract in dis-
tilled water and washing with n-hexane, diethyl ether or chloroform [12]. Attention must
be payd, that the substances responsible for the antioxidant activity are not removed from
the extract. Shui and Peng [51] found only a small loss of antioxidant activity when
further extraction with hexane were performed, thus hexane was chosen to remove the
chlorophyll from the plant extract.
Some secondary metabolites may be sensitive to light, hence the plant extract should be
protected from light exposure.
3.3.1 Chemicals and equipment: ultrasound-assisted methanolic extraction
• n-Hexane
• Methanol
• Herniaria incana
• Aluminum foil
• Büchner funnel
• Filter paper (Schleicher and Schuell no. 589)
• Preweighed round-bottom flasks.
• Rotary evaporator
• Ultrasonic bath
• Vacuum pump
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3.3.2 Procedure: ultrasound-assisted methanolic extraction
1. Accurately measure out 10.0 g of Herniaria incana, carefully broken into smaller
pieces, and put it into a round-bottom flask.
2. Add 500 mL of methanol.
3. Sonificate the plant material on ultrasonic bath for 20 minutes.
4. Let stay for 12 hours covered with aluminum foil.
5. Have the plant material on ultrasonic bath for 20 minutes.
6. Pour out the methanolic plant extract and add new 500 mL of methanol to the plant
residue.
7. Repeat the procedure five times.
8. Filter the methanolic plant extract twice under vacuum using an Büchner funnel
and filterpaper no. 589 (Schleicher and Schuell).
9. Evaporate the extract til dryness under vacuum at 40 ◦C using a rotary evaporator.
10. Measure the weight and calculate the yield.
11. Keep the dry plant extract in refrigerator at 2.2 ◦C covered with aluminum foil until
further use.
3.3.3 Chemicals and equipment: extraction with n-hexane
• Distilled water
• Methanolic extract of Herniaria incana
• n-Hexane
• Aluminum foil
• Beakers to collect the different phases in.
• Preweighed round-bottom flasks.
• Rotary evaporator
• Separating funnel, 250 mL
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• Preweighed round-bottom flasks.
3.3.4 Procedure: extraction with n-hexane
1. Dissolve 0.25 or 1.4 g of the dry methanolic extract in 25 or 50 mL of distilled
water, respectively, and transfer it into a separating funnel.
2. Add an equal amount of n-hexane (25 or 50 mL) and shake.
3. Let the mixture rest until the layers have separated (20 minutes).
4. Pour the hexane phase into a clean round-bottom flask and keep in the refrigerator
covered by aluminum foil.
5. Repeat the procedure three times.
6. Evaporate the aqueous phase under vacuum at 40 ◦C using a rotary evaporator.
7. Add a few drops of hexane and evaporate until dryness.
8. Measure the weight and calculate the yield.
9. Keep the dry plant extract in refrigerator at 2.2 ◦C covered with aluminum foil until
further use.
3.4 Estimation of the total ﬂavonoid content
Flavonoids are known to scavenge free radicals and have strong antioxidant activity [8],
hence it is interesting to investigate the total flavonoid content of the plant extract.
The total flavonoid content of the methanolic extract of Herniaria incana will be deter-
mined using a UV-VIS spectrophotometer, according to the method of Hsu [52].
When the plant extract is incubated with aluminum nitrate, aluminum nitrate forms an
acid stable complex with the keto group and either the hydroxyl group in ring A or ring
C of flavonoids (see figure 2 in section 1.5.1). It also forms acid unstable complexes
with orthodihydroxyl groups in ring A or ring B. The complexes absorbs light strongly
at 415 nm and can be detected on UV-VIS spectroscopy [53]. The absorbance of the
complexes formed between the plant extract and aluminum nitrate are compared with
that of a standard, often quercetin [52].
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3.4.1 Chemicals and equipment
• Aluminum nitrate
• Ethanol, 80 %
• Extract of Herniaria incana
• Potassium acetate
• Quercetin
• 2 automatic pipette
• Disposable UV cells, 2.5 mL
• 2 graduated pipette, 5 mL
• 10 test tubes (5 mL) with cap
• UV-VIS spectrophotometer: Cecil (CE9500) 9000 Series
• 1 volumetric flask with cap, 500 mL
• 1 volumetric flask with cap, 100 mL
• 5 volumetric flasks with cap, 50 mL
• 5 volumetric flasks with cap, 10 mL
3.4.2 Procedure: The aluminum-nitrate method
1. Make the 80 % ethanol solution (450 mL 99.8 % ethanol + 50 mL distilled water).
2. Prepare the 10 % (10 g/ 100 mL) aluminum nitrate solution. Accurately measure
out 1 g of aluminum nitrate and quantitatively transfer it to a 10 mL volumetric
flask. Adjust the volume to 10 mL with 80 % ethanol. Shake.
3. Prepare the 1 M potassium acetate solution. Accurately measure out 981.4 mg of
potassium acetate and quantitatively transfer it to a 10 mL volumetric flask. Adjust
the volume to 10 mL with 80 % ethanol. Shake.
4. Prepare the standard solutions using quercetin dissolved in 80% ethanol as standard
(2.5, 5, 10, 15, 20 µg/mL): accurately measure out 25 mg of quercetin. Quanti-
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tatively transfer it to a 100 mL volumetric flask. Adjust the volume with 80%
ethanol. Shake well.
5. Transfer 0.5, 1, 2, 3 and 4 mL, respectively, of this solution into five 50 mL volu-
metric flasks. Adjust the volume with 80% ethanol. Shake well.
6. Prepare the sample solutions. Measure out 5.0 mg, 7,5 mg and 10.0 mg of the
extract and dissolve it in 80% ethanol to a total volume made up to 10.0 mL. Use
the ultrasonic bath to dissolve.
7. Into 10 test tubes put 0.1 mL of 10 % aluminum nitrate, 0.1 mL of 1 M potassium
acetate and 4.3 mL of 80 % ethanol.
8. Add an aliquot of 0.5 mL of the sample/standard/solvent (control) to the test tubes.
Mix. Note the time.
9. Incubate at room temperature for 40 minutes.
10. Measure the absorbance of the supernatant at 415 nm. 80 % ethanol as blank.
11. Make a standard curve of quercetin by plotting the concentration of quercetin
against the absorbance. Make a linear curve (Y = ax + b) by linear regression.
12. Calculate the total flavonoid content of the plant extract as µg quercetin equivalents
per milligram dry weight (dw) plant extract, using the equation obtained from the
standard curve.
13. Calculate the mean and standard deviation of the parallels.
3.5 The Folin-Ciocalteu reagent reducing capacity assay
The method was introduced by Singleton and Rossi in 1965 as a simple way to determine
the total phenolic content of wine [54], and has been used to determine the total pheno-
lics in natural products. However, the Folin-Ciocalteu reagent can be reduced by many
non-phenolic compounds, e.g. vitamin C and Cu(I). Thus the term "total phenolic con-
tent" is not suitable, unless interfering species are considered or removed [20]. Several
correlations between the Folin-Ciocalteu assay and other electron-transfer assays con-
firm the value of the Folin-Ciocalteu reagent for the assessment of antioxidant capacity
[20].
The exact chemical nature of the Folin-Ciocalteu reagent is not known, but it is believed
to contain complex polymeric ions formed from phosphomolybdic and phosphotungstic
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heteropoly acids [54, 2]. The basic mechanism of the assay is a single electron transfer
reaction between the reductants and molybdenum (Mo). As showed in equation (5),
the electron from the antioxidant reduces molybdenum from Mo(VI) to Mo(V) [2]. This
results in the formation of a blue complex absorbing light at 750-765 nm [20]. A linear
correlation between the absorbance of the complex and concentration of the reducing
species has been established [54].
Mo(V I)+ e−→Mo(V ) (5)
The Folin-Ciocalteu reducing capacity will be estimated according to the procedure of
Singleton et. al. [55] and gallic acid is used as standard. The results are expressed as
microgram gallic acid equivalents (GAE) per milligram of dry plant extract.
3.5.1 Chemicals and equipment
• Distilled water
• Ethanol
• Extract of Herniaria incana
• Folin-Ciocalteu reagent
• Gallic acid
• Sodium carbonate anhydrous
• Aluminum foil
• 1 automatic pipette, 0.500 mL
• Disposable UV cells, 2.5 mL
• Measuring ship
• 2 pipettes, 5 mL
• Test tubes with caps.
• UV-VIS spectrophotometer: Cecil (CE9500) 9000 Series
• 3 volumetric flasks with cap, 10.0 mL
22
• 8 volumetric flasks with cap, 100 mL
• 1 volumetric flasks with cap, 50 mL
3.5.2 Procedure: the Folin-Ciocalteu reagent reducing capacity assay
1. Turn on the UV-apparatus.
2. Cover all volumetric flasks and test tubes with aluminum foil.
3. Prepare the sample solutions. Accurately measure up 0.1000 g of plant extract and
quantitatively transfer it into a 10 mL volumetric flask. Adjust the volume to 10
mL using distilled water.
4. Prepare the 7.5% (7.5 g/100 mL) sodium carbonate solution. Accurately measure
out 7.5 g of sodium carbonate anhydrous and quantitatively transfer it to a 100 mL
volumetric flask. Adjust the volume with distilled water.
5. Make the Gallic Acid stock solution. Accurately measure out 0.050 g of dry gallic
acid and dissolve it in 10 mL ethanol in a 100 mL volumetric flask. Adjust the
volume to 100 mL with distilled water.
6. Prepare the standard solutions using gallic acid dissolved in distilled water (5, 10,
15, 25 and 50 (µg/mL)): quantitatively transfer 1, 2, 3, 5 and 10 mL of the gallic
acid stock solution into five 100 mL volumetric flasks, respectively. Adjust the
volume with distilled water. Shake well.
7. Dilute the Folin-Ciocalteu reagent. Using a graduated pipette measure up 10 mL of
the Folin-Ciocalteu reagent and transfer it into a 100 mL volumetric flask. Adjust
the volume to 100 mL with distilled water.
8. Using an automatic pipette transfer 0.5 mL of the samples into test tubes. One
sample of each standard and three parallels of the plant extract.
9. Add 2.5 mL of diluted Folin-Ciocalteu reagent to the sample in the test tubes. Use
a graduated pipette. Shake. Note the time. (Prepare a new one every 4 minute.)
10. After 2 minutes add 2 mL 7.5% sodium carbonate. Shake. Note the time.
11. Let stand for 2 hours in room temperature.
12. Measure the absorbance at 760 nm against the control (distilled water and reagent).
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13. Make a graph by plotting absorbance against the concentrations of the standard
curve. Find the equation. Determine the Folin-Ciocalteu reducing capacity as µg
gallic acid equivalents of mg dw plant extract by using the standard curve.
14. Calculate the mean and standard deviation of the parallels.
3.6 The phosphomolybdenum reducing capacity assay
The antioxidant capacity of Herniaria incana is determined using the phosphomolybde-
num assay as proposed by Prieto et. al. [56]. The method was first used to evaluate the
antioxidant capacity of corn and soybean seeds, and have later been extended to evaluate
the antioxidant capacity of plant extracts [49, 57, 58].
It is a spectrophotometric method based on the reduction of Mo(VI) to Mo(V) (SET-
based) by the sample analyte followed by the formation of a green phosphate/Mo(V)
complex at acidic pH. The absorbance maximum of the complex is measured at 695 nm
[56]. The results are presented as mmol α-tocopherol equivalents per gram of dried plant
extract [57].
3.6.1 Chemicals and equipment
• α-tocopherol
• Ammonium molybdate
• Concentrated sulfuric acid
• Extract of Herniaria incana
• Methanol
• Sodium phosphate
• 1 automatic pipette, 0.3 mL
• 1 automatic pipette, 3.0 mL
• Disposable UV cells: 2.5 mL
• Heath plate
• 9 vials with cap
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• 9 test tubes with caps
• Thermometer
• UV-VIS spectrophotometer: Shimadzu UV Mini-1240
• 1 volumetric flasks with caps, 50 mL
3.6.2 Procedure: The phosphomolybdenum method
1. Make the reagent solution: 0.6 M sulfuric acid, 28 mM sodium phosphate, 4 mM
ammonium molybdate tetrahydrate. Accurately measure up 1.6 mL of sulfuric
acid, 0.2295 g of sodium phosphate and 0.2472 g of ammonium molybdate and
quantitatively transfer it to a 50 mL volumetric flask. Adjust the volume with
methanol. First measure up the sulfuric acid into a small cleaner beaker containing
ca 12 mL of methanol. Use this to transfer the sodium phosphate and ammonium
molybdate into the volumetric flask. Be careful and do not allow contact of the
reagent or any other solutions with aluminum foil.
2. Prepare the sample solutions. Measure up 0.0500 g in a vial and dissolve it in 1
mL of methanol.
3. Prepare the standard solutions using α-tocopherol dissolved in methanol (150 mg/mL).
Preweigh a vial with a cap containing 5 mL of methanol. Add an appropriate
amount (0.7500 g) of α-tocopherol using a plastic spoon. Weigh the sample glass
with cap again. Calculate the concentration. If necessary dilute the stock solution.
4. Transfer 100, 200, 400, 600, 800, 1000 and 1300 µL respectively, of this solution
into vials. Make up the volume with methanol, so that the total volume is 5 mL.
Shake well.
5. Put 3.0 mL of reagent solution in each of the 9 test tubes.
6. To the test tubes add 0.3 mL of sample (three parallels) / standard (one parallel) /
methanol(control). Prepare a new one every 5 minutes.
7. Cap the tubes and incubate in a boiling water bath [9] at 95 ◦C for 90 minutes.
8. Cool the samples to room temperature (wait for fifty minutes). Measure the ab-
sorbance of the aqueous solution at 695 nm against the control.
9. Make a standard curve. y = absorbance and x = concentrations of α-tocopherol
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in mmol/mL. Find the equation. Express the total antioxidant capacity as mmol
equivalents of α-tocopherol per gram of dried plant extract.
10. Make a standard curve. y = absorbance and x = concentrations of α-tocopherol in
µg/mL. Find the equation. Express the total antioxidant capacity as µg equivalents
of α-tocopherol per milligram of dried plant extract.
11. Calculate the mean and standard deviation of the parallels.
3.7 The DPPH free radical scavenging assay
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay is one of the
most popular antioxidant assays used by almost 90 % of antioxidant studies [1]. DPPH
is a stable and commercially available organic nitric radical giving a purple solution in
methanol [1]. The assay is based on an electron-transfer (SET) reaction, where DPPH is
reduced by the sample to 2,2-diphenyl-1-picrylhydrazine, which gives a yellow solution
[20]. The SET-based reaction is shown in figure 8.
Figure 8: The reduction of 2,2-diphenyl-1-picrylhydrazyl to 2,2-diphenyl-1-
picrylhydrazine, and their respective absorption spectrum [59]
The DPPH free radical scavenging capacity is determined using UV-VIS spectroscopy
according to the method of Molyneux [60].
The purple DPPH solution can be detected using UV-VIS spectroscopy at 515-528 nm.
By letting the DPPH react with the plant extract at different concentrations, the scav-
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enging activity can be evaluated by measuring the decrease in the absorbance [20]. The
scavenging activity is often represented as inhibition percentage (I%) [61]:
I% =
Abs0−Abs1
Abs0
(6)
Abs0 = The absorbance of the negative control
Abs1 = The absorbance of the sample/standard
Several factors may influence the results, such as solvent, pH, concentration of the reagent,
concentration of the samples, reaction time and processing data [60, 61].
The antioxidant capacity is proportional to the decrease in absorbance. This relationship
is not linear [1, 61]. The results are often presented as EC50, the amount of antioxidant
necessary to decrease the initial DPPH concentration by 50 % [62]. The EC50 value of
the plant extract will be compared with a standard, in this case ascorbic acid. A lower
value of EC50 indicates greater antioxidant activity [63].
When plotting the scavenging activity of the sample versus the concentration, an s-shaped
curve is given, as showed in figure 9. In literature many ways for obtaining the EC50 are
reported. Some articles report that the EC50 values are obtained from regression lines,
without mentioning the regression model used [11]. One way to obtain the EC50 is to
apply linear regression to the linear parts of the curve. Nikolova et. al calculated the
EC50 by sigmoid non-linear regression model [64]. In an article by Locatelli et. al., it
is argued that the accuracy of the obtained EC50 value, achieved by linear regression
from the linear parts of the plot, would be significantly affected [61]. A linear relation
between the percentage of inhibition and sample concentration is confirmed only for a
limited range of concentrations, and it is indicated that it would be erroneous to employ
the linear regression for the calculation of EC50 over 70% [61]. Locatelli et. al. suggested
to calculate the EC50 value by the Probit regression model, as it’s was found to fit well to
the antiradical activity curves. The Probit regression model has also been used in other
studies evaluating the DPPH free radical scavenging assay [61].
Some of the main limits of the DPPH assay is the non-existence of DPPH or similar
compounds in biological systems, and the steric accessibility of DPPH radicals. Smaller
molecules have better access to the radical site of the DPPH molecule and therefore may
show higher antioxidant activity than larger molecules [20].
As mentioned earlier, chlorophyll and other substances, as carotenoids, may absorb light
at the wavelength of measurement and interfere with the results. This may be avoided to
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Figure 9: An example of the s-shaped curve given when the DPPH scavenging activity is
plotted against the concentration of the samples [65]
a certain degree by using the plant sample without reagent as a blank, which is normal
procedure in the DPPH assay.
The DPPH solution decomposes with time and should be used within two hours after
preparation. The effect of temperature is more dramatic than the effect of time, so it
is better to keep for a short period of time at room temperature, than refrigerating the
solution [62]. DPPH is light sensitive, and the samples should be protected from strong
light [66].
3.7.1 Chemicals and equipment
• Ascorbic Acid
• DPPH
• Extract of Herniaria incana
• Methanol
• Aluminum foil
• Appropriate automatic pipettes with tips
• Card board box
• Disposable UV cuvettes 1.5 mL
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• Magnet
• Magnetic stirrer
• 9 vials with cap
• 18 test tubes with caps
• UV-VIS spectrophotometer: Shimadzu UV Mini-1240
• 2 volumetric flasks with caps, 100 mL
3.7.2 Procedure: the DPPH free radical scavenging assay
1. Turn on the single beam UV apparatus one hour before use.
2. Mark a clean test tube with Ca. This will be the blank to the negative control.
3. Mark a clean vial with Cb. This will be the negative control.
4. Mark eight clean test tubes with 1a, 2a, 3a, 4a, 5a, 6a, 7a and 8a. These will be
containing the blanks to the samples.
5. Mark eight clean vials with 1b, 2b, 3b, 4b, 5b, 6b, 7b and 8a. These will be
containing the samples.
6. Make the stock solution of a) the standard (ascorbic acid) (0.25 mg/mL) or b) Plant
sample (Herniaria incana (0.80 mg/mL).
a) Accurately measure out 0.0100 g of ascorbic acid and quantitatively transfer it
into a 100 mL volumetric flask. Make up the volume with Methanol.
b) Accurately measure out 0.090 g of dry methanolic extract of Herniaria incana
and dissolve it in 6 mL of methanol.
7. Make standard solutions of a) ascorbic acid or b) plant extract. Eight different
concentrations of the stock solution. Pre-tests with various concentrations were
performed in order to find the concentration range which corresponds to the linear
dependence of absorption versus concentration.
a) Ascorbic acid (2.0, 4.0, 6.0, 8.0, 10.0, 12.0, 14.0, 16.0 (µg/mL)): Transfer 0.100,
0.200, 0.300, 0.400, 0.500, 0.600, 0.700 and 0.800 mL of the stock solution into
eight test tubes using an automatic pipette. Make the total volume up to 5 mL by
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adding 4.9, 4.8, 4.7, 4.6, 4.5, 4.4, 4.3 and 4.2 mL of methanol, respectively, using
an automatic pipette.
b) Plant extract (60, 87, 113, 141, 164, 188, 211, 233 (µg/mL)): Transfer 0.200,
0.300, 0.400, 0.500, 0.600, 0.700, 0.800 and 0.900 mL of the stock solution and
add 5 mL of methanol using an automatic pipette.
8. Using an automatic pipette transfer 2 mL of methanol into the vials marked with a
and Cb and at least 4 mL methanol into Ca.
9. Using an automatic pipette transfer 2 mL of standard solution into the correspond-
ing vials. Example: 2 mL of standard solution S1 into 1a and 1b. 2 mL of standard
solution S2 into 2a and 2b.osv...
10. Make the DPPH solution (0.1 mM). Accurately measure out 0.0039 g of DPPH and
quantitatively transfer it into a 100 mL volumetric flask. Shake it well. Dissolve
using a magnetic stirrer. Cover it with aluminum foil for protection against light.
11. With 4 minutes interval add 2 mL of DPPH solution to all sample glass marked
with b. Start with Cb. Shake well (20 shakes) and put it in the card board box.
12. Let stand for 30 minutes in the dark (card board box), before measuring the ab-
sorbance at 517 nm against it’s own blank. Example: Autozero the spectropho-
tometer with Ca, 1a, 2a before measuring the absorbance of Cb, 1b, 2b...
13. Calculate the scavenging activity [62]:
I =
Abs0−Abs1
Abs0
(7)
14. Calculate the Probit of the scavenging activity. Make a graph by plotting log of the
concentrations against the Probit of the scavenging activity.
15. Make a linear regression line and generate an equation Y = aX + b. From this
equation calculate EC50. The Probit of 50 % scavenging is zero, thus the EC50 is
calculated as:
EC50 = 10
−b
a (8)
16. Calculate the mean and standard deviation of the parallels.
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4 Results
4.1 Extraction of Herniaria incana
Figure 10 shows the extract after extraction with methanol, before it is evaporated to
dryness. The methanolic extraction of H. incana had a deep green colour. The first
extract looks like a paste and is difficult to get completely dry. After extraction with
hexane and removal of oily compounds, the extract looks more like a powder.
Figure 10: The methanolic extract of Herniaria incana had a dark green colour. Photo:
S.M. Parmer
Table 2 shows yield of the extractions. Extract A and B origins from 2009, while extract
C origins from 2010. Extract A was used to determine the total flavonoid content (TFC),
extract B was used in the Folin-Ciocalteu reducing capacity assay (FCA), while extract
C was used in the phosphomolybdenum assay (PMA) and in the DPPH free radical scav-
enging assay (DPPH-A).
Table 2: Weight percent yield from the extraction of Herniaria incana
Extraction Harvested Yield 1 (w%) Yield 2 (w%) Total yield (w%) Used in:
A 08.06.2009 14.85 82.87 12.31 TFC
B 08.06.2009 14.85 93.87 13.94 FCA
C 18.05.2010 14.47 83.81 12.13 DPPH-A, PMA
Yield 1 is the yield of extract from the crude drug after methanolic extraction, yield 2 is
the yield of extract from the first extract after extraction with hexane, while the total yield
represents the yield after extraction with hexane in relation to the crude drug. The total
yield of extractions A, B and C is 12.31, 13.94 and 12.13 w% respectively.
See appendix D.1 for more detailed data.
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4.2 Estimation of the total ﬂavonoid content
The total flavonoid content was determined by the aluminum nitrate method with UV-
VIS spectrophotometry according to the method of [52]. Figure 11 shows the standard
curve of quercetin, with absorbance of the aluminum-nitrate complex plotted on the y-
axis and the concentration of quercetin in microgram per milliliter on the X-axis. The
equation f(x) = 0.0604x-0.0027 (R2 = 0.9973) was obtained by linear regression. From
this equation the total flavonoid content (TFC) of the plant extract was calculated as
micrograms of quercetin equivalents (QUE) per milligram of the dry plant extract.
Figure 11: The standard curve of quercetin used to determine the total flavonoid content
of Herniaria incana
Table 3 show the concentration, the absorbance, the QUE calculated from the equation
and the TFC of the plant samples. The results are presented as mean± standard deviation
(SD) of three parallels. The total flavonoid content of H. incana was estimated to be
20.46 ± 0.07 microgram quercetin equivalents per milligram of the dry weight extract.
For example of calculation see appendix E.1.
See appendix D.2 for more detailed data.
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Table 3: The estimation of the total flavonoid content of Herniaria incana
Sample Concentration (mg/mL) Absorbance QUE (µg/mL) TFC (µg QUE/mg)
1 0.024 0.027 0.49172 20.48841
2 0.055 0.065 1.12086 20.37929
3 0.070 0.084 1.43543 20.50615
Mean - - - 20.46
SD - - - 0.07
4.3 The Folin-Ciocalteu reagent reducing capacity assay
The Folin-Ciocalteu reagent reducing capacity (FCRC) was determined with UV-VIS
spectrophotometry using the method of Singleton et. al [55]. Figure 12 shows the stan-
dard curve of gallic acid, with absorbance of the reaction complex plotted on the Y-
axis and the concentration of gallic acid in microgram per milliliter on the X-axis. The
equation f(x) = 0.1171+0.0500 (R2 = 0.9970) was obtained by linear regression. From
this equation the Folin-Ciocalteu reagent reducing capacity of the plant extract was cal-
culated as micrograms of gallic acid equivalents (GAE) per milligram of the dry plant
extract.
Figure 12: The standard curve of gallic acid used to determine the Folin-Ciocalteu re-
ducing capacity of Herniaria incana
Table 4 show the concentration, the absorbance, the GAE calculated from the equation
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and the FCRC of the plant samples. The results are presented as mean ± standard devi-
ation of three parallels. The Folin-Ciocalteu reagent reducing capacity of H. incana was
estimated to be 35.0 ± 1.6 microgram gallic acid equivalents per milligram of the dry
weight extract. For example of calculation see appendix E.2.
Table 4: The estimation of the Folin-Ciocalteu reducing capacity of Herniaria incana
Sample Concentration (mg/mL) Absorbance GAE (µg/mL) FCRC (µg GAE/mg)
1 0.1018 0.446 3.38173 33.21930
2 0.1018 0.478 3.65500 35.90369
3 0.1018 0.478 3.65500 35.90369
Mean - - - 35.0
SD - - - 1.6
See appendix D.3 for more detailed data.
4.4 The phosphomolybdenum reducing capacity assay
The antioxidant activity was determined by the phosphomolybdenum assay using UV-
VIS spectrophotometry as described by Prieto et. al. [56]. Due to different manners for
presenting the results in the literature, the results are presented in two different ways. This
will make it easier to compare the results of the phosphomolybdenum reducing capacity
of H. incana with that of other plant species.
Figure 13 shows the standard curves of α-tocopherol, with absorbance of the complex
formed plotted on the Y-axis and the concentration of α-tocopherol on the X-axis pre-
sented as mmol/mL and µg/mL, respectively. The equations f(x) = 64.7671x + 0.0724
(R2 = 0.9840) and f(x) = 0.00015x + 0.07236 (R2 = 0.9840) were obtained by linear re-
gression. From this equations the phosphomolybdenum reducing capacity (PMRC) of the
plant extract, was calculated as millimols of α-tocopherol equivalents (ATE) per gram of
the dw plant extract, and micrograms of ATE per milligram of the dw plant extract.
Table 5 show the concentrations, the absorbance, the ATE calculated and the PMRC
of the plant samples. The results are presented as mean ± standard deviation of three
parallels. The phosphomolybdenum reducing capacity of H. incana was estimated to be
0.84± 0.25 millimol α-tocopherol equivalents per gram of the dry weight extract, or 362
± 106 µg α-tocopherol equivalents per milligram of the dry weight extract. For example
of calculation see appendix E.3.
It was observed that the reagent rapidly formed a blue colour when it came in contact
with aluminum foil or air.
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(a) α-tocopherol expressed as mmol/mL
(b) α-tocopherol expressed as µg/mL
Figure 13: The standard curve of α-tocopherol used in the phosphomolybdenum reducing
capacity assay presented as (a) mmol/mL and (b) µg/mL
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Table 5: The phosphomolybdenum reducing capacity assay of Herniaria incana pre-
sented as (mmol ATE/g) and (µg ATE/g)
Sample Concentration (g/mL) Absorbance ATE (mmol/mL) PMRC (mmol ATE/g)
1 0.004173 0.249 0.002727 0.6535
2 0.004173 0.273 0.003113 0.7460
3 0.004173 0.374 0.004657 1.1160
Mean - - - 0.84
SD - - - 0.25
Sample Concentration (mg/mL) Absorbance ATE (µg/mL) PMRC (µg ATE/mg)
1 4.1727 0.249 1177.60 282.22
2 4.1727 0.274 1344.27 322.16
3 4.1727 0.374 2010.93 481.93
Mean - - - 362
SD - - - 106
See appendix D.4 for more detailed data.
4.5 The DPPH free radical scavenging assay
The DPPH free radical scavenging capacity of ascorbic acid and H. incana was deter-
mined using UV-VIS spectrophotometry, and are presented as the concentration of reduc-
ing reagent necessary to decrease the initial DPPH concentration by fifty percent (EC50)
[60]. Figure 14(a) and 14(b) show an example of the standard curves of ascorbic acid
and Herniaria incana, respectively. See appendix C for the standard curves of the other
parallels. The Probit of the scavenging activity is plotted on the Y-axis, while the log
concentration of the reductant is plotted on the X-axis. The equations, Y = aX + b, were
obtained by linear regression. The a-value, b-value, R2 and EC50 for all the parallels of
ascorbic acid and H. incana are presented in table 7 and 6, respectively. For example of
calculation see appendix E.4.
Table 6: The results from the DPPH free radical scavenging of Herniaria incana
Date a b R2 EC50 (µg/mL)
12.04.12 3.8150 -7.2018 0.9960 77.23
13.04.12 3.2147 -5.8283 0.9990 65.02
Mean - - - 71.1
SD - - - 8.6
The results from the DPPH free radical assay of ascorbic acid are shown in table 7. The
EC50 was determined to 6.6 ± 1.0 µg/mL. The results are presented as mean ± standard
deviation of five parallels.
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(a) The DPPH free radical scavenging of ascorbic acid 09.04.12
(b) The DPPH free radical scavenging of Herniaria incana 12.04.12
Figure 14: Examples of standard curves used to calculate the EC50 value of the DPPH
free radical scavenging of (a) ascorbic acid and (b) Herniaria incana
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Table 7: The results from the DPPH free radical scavenging of ascorbic acid
Date a b R2 EC50 (µg/mL)
02.04.12 7.4117 -6.2679 0.9926 7.17
04.04.12 8.5174 -6.3430 0.9895 5.56
06.04.12 10.8883 -9.2774 0.9938 7.11
09.04.12 7.9888 -5.8424 0.9984 5.39
10.04.12 10.5707 -9.3396 0.9870 7.65
Mean - - - 6.6
SD - - - 1.0
Table 6 shows the DPPH free scavenging of H. incana. The EC50 was determined to
71.1 ± 8.6 µg/mL. The results are presented as mean ± standard deviation of two paral-
lels.
See appendix D.5 for more detailed data.
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5 Discussion
5.1 Extraction of Herniaria incana
H. incana was first extracted in methanol and subsequently with hexane, in order to
remove substances like carotenoids and chlorophyll, that might interfere with the UV
absorbance in the following assays (see section 3.1). An emulsion of the aqueous and
the hexane phase was easily formed during shaking of the separating funnel. Most of the
emulsion settled and separated after twenty minutes.
There are little variation of yield of the different extracts. Extract B, used in the Folin-
Ciocalteu assay, has a slightly higher second yield than the others. This may be due
to less emulsion formed during the extraction, and subsequently lesser amount of loss
of water-soluble substances. It may also mean that less hexane-soluble substances have
been extracted from the aqueous phase, with the consequence of more chlorophyll in
extract B.
Due to a lack of more crude drug from 2009, plant extract C is from another year and
month than extract A and B. Although they are harvested in the same area, factors like
climate, soil and month of harvest may effect the amount of secondary metabolites with
antioxidant activity in the plant. This fact needs to be taken into account when the results
from the different assays are compared.
5.2 Estimation of the total ﬂavonoid content
Flavonoids are known for their antioxidant properties, and the flavonoid content of the
investigated plant is of interest when evaluating its antioxidant properties. A positive cor-
relation between the content of flavonoids and the antioxidant capacity in plant extracts
have been found [9]. The methanolic extract of H. incana was found to have a content
of 20.46 ± 0.07 microgram quercetin equivalents per milligram of the dry weight ex-
tract.
There is little data on the flavonoid content of different Herniaria species, so the esti-
mated content of flavonoids in H. incana can not be compared to that of other Herniaria
species.
In a study of Wrightia tomentosa, the flavonoid content was estimated to 16.9 and 20.3
µg quercetin equivalents per mg of dry ethanolic extract [9]. Investigations of Polygonum
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aviculare showed a total flavonoid content of 112.7 mg quercetin equivalents per g of dry
ethanolic extract, corresponding to 112.7 µg/mg [52]. The results of flavonoid content
of Wrightia tomentosa, Polygonum aviculare and H. incana are obtained by the same
method.
The flavonoid content estimated for Wrightia tomentosa corresponds well with the re-
sults obtained for H. incana, while that reported for Polygonum aviculare is considerable
higher. This may suggest that H. incana have moderately content of flavonoids. More
data from similar studies must be reviewed before a conclusion of the significance of the
flavonoid content of H. incana can be drawn.
The absorbance of the standard curve are a bit lower than recommended (see section
3.1). This may have resulted in lower precision. The coefficient of determination (R2)
of the equation describing the standard curve have a value of 0.9973, suggesting that
the standard curve has a good linear correlation, even though the absorbance are a bit
low.
5.3 The Folin-Ciocalteu reagent reducing capacity
The Folin-Ciocalteu reagent assay is a very popular antioxidant assay for the estima-
tion of the reducing capacity of a plant extract. The results are presented as the total
phenolic content or the Folin-Ciocalteu reducing capacity (FCRC), and reported as mg
GAE/g.
The majority of the Folin-Ciocalteu reducing capacity results reported for different plant
extracts lies between 13 and 50 mg gallic acid equivalents per gram dry weight extract
[67, 10, 48]. Higher values of 155 mg/g [10] and 677 mg/g [52] have also been reported.
The reducing capacity of H. incana is estimated to 35.0 ± 1.6 µg GAE/mg, suggesting a
moderately good ability to scavenge the Folin-Ciocalteu reagent, compared to other plant
extracts.
The standard curve of gallic acid have a good linear approximation with a R2 of 0.9970.
There is little data of the Folin-Ciocalteu reducing capacity of different Herniaria species,
so the Folin-Ciocalteu reducing capacity of H. incana can not be compared to that of other
Herniaria species.
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5.4 The phosphomolybdenum reducing capacity assay
The results of the phosphomolybdenum reducing capacity assay are presented in a vari-
ous different ways in the literature. In the original article the results are presented as 100-
200 nmol α-tocopherol / g of seeds from corn and soybeans [56]. Other studies have pre-
sented the results as 1000-2300 mmol α-tocopherol/g of turmeric oil [68], 0.06-118 µmol
α-tocopherol/g of fresh tissue from various fruit peel, seed or leaf[50], 4.2-8.3 µg/mg dry
extract of bark and leaf from Wrightia tomentosa [9], 3.2-5.4 mM α-tocopherol acetate/g
dry mass of aerial parts from Hypericum perforatum, Hypericum empetrifolium and Hy-
pericum triquetrifolium [57] and 14-23 mM α-tocopherol acetate/g dry mass of leaves
from Ficus carica [58].
The huge difference of order, and the diverse manners of presenting the results in the
distinct studies, make the interpretation of the results more difficult. It was considered
best to compare the reducing capacity of the methanolic extract of H. incana with the
results of other dried herbs, hence it is presented as both (mmol ATE/g) and (µg ATE/g).
The phosphomolybdenum reducing capacity of H. incana was estimated to be 0.84 ±
0.25 millimol α-tocopherol equivalents per gram of the dry weight extract, or 362 ± 106
µg α-tocopherol equivalents per milligram of the dry weight extract.
The reducing capacity of H. incana determined by the phosphomolybdenum method is
around four times lower than that reported for the three Hypericum species [57], and
fifteen times lower than that reported for Ficus carica [58]. On the other side, the reduc-
ing capacity of H. incana is much higher (362 µg/mg) than that reported for Wrightia
tomentosa [9].
It was observed a blue colour, when the reagent was exposed to aluminum foil or air. A
possible reason for the formation of the blue colour is oxidation of the reagent. This may
have affected the accuracy of the standard curve. Although precautions were taken for
avoiding formation of the blue colour, two of the standard solution samples had different
colours and much higher absorbance than the other samples. These two samples were
excluded from the standard curve. Further investigations of stability of the reagent would
be necessary in order to reveal the effect the formation of the blue colour may have on
the accuracy of the standard curve.
The standard curve of α-tocopherol has a good linear approximation with an R2 of
0.9840. The standard deviation of the plant samples show low precision. This might
be improved by performing more parallels.
In the phosphomolybdenum assay, a blue colour was formed in some of the samples. The
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results did not show very good precision. The precision might be improved by performing
more parallels, however, due to difficulties in this assay, it should be considered if it
would be good to replace this experiment in future studies.
5.5 The DPPH free radical scavenging assay
The DPPH free radical scavenging assay is one of the most used assays for evaluation of
the antioxidant properties of a plant sample. Despite the huge number of data available,
comparison of the results from different studies can not be directly compared to each
other. Several factors may influence the results, such as solvent, pH, concentration of
the reagent, concentration of the samples, reaction time and processing data [60, 61].
In many articles it is not mentioned how the EC50 value is calculated, which makes it
difficult to compare results from different studies [62].
The EC50 of the plant extracts are compared to that of a standard, usually ascorbic acid
[60]. Mishra et. al. pointed out that the EC50 reported for ascorbic acid varied enor-
mously from 5.85 to 110.77 µg/mL [69], demonstrating the differences in the results due
to the factors mentioned above.
The EC50 of H. incana was determined to 71.1 ± 8.6 µg/mL, compared to that of 6.6 ±
1.0 µg/mL for ascorbic acid.
Nikolova et. al. considered plant extract with EC50 below fifty µg/mL to exhibit strong
DPPH radical scavenging activity, plant extracts with EC50 between fifty and hundred
µg/mL to possess significant activity, and those with an EC50 above 200 µg/mL to have
little activity [64].
The EC50 has been determined to 54 to 62 µg/mL for leaves, twigs and stem bark of
Canarium album compared to 78.25 µg/mL for asorbic acid [70]. The EC50 for the leaf,
stem bark and root bark of Acacia confusa determined to 89 to 113 µg/mL, compared
to 118 µg/mL for ascorbic acid [63]. The EC50 for bark and leaf ethanolic extract of
Wrightia tomentosa estimated to 75 and 135 µg/mL compared to 3.1 µg/mL for ascorbic
acid [9].
According to Nikolovas classification, H. incana exhibit a moderately DPPH radical
scavenging activity. Keeping in mind that the variations of the procedure may effect
the outcome of the results, H. incana has similar DPPH free radical scavenging activity
compared to the other plant species mentioned above. However, when the EC50 of the
plant extracts are compared to that of ascorbic acid, H. incana and Wrightia tomentosa
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have much higher value of EC50 than ascorbic acid, while Canarium album and Acacia
confusa have lower values of EC50 than ascorbic acid. Reminding that a lower value
of EC50 means a higher radical scavenging acitivty, this may indicate that H.incana has
similar DPPH scavenging activity as the bark of Wrightia tomentosa, and lower than
Canarium album and Acacia confusa.
There are very few studies that have evaluated the DPPH free radical scavenging of Her-
niaria species, but one article reported little antioxidant activity (EC50 more than 200
µg/mL) for H. glabra, compared to 3.15 for quercetin [64]. This may indicate that H.
incana is a better DPPH free radical scavenger than its close relative H. glabra.
The standard curves of ascorbic acid shows a good linear approximation with a R2 be-
tween 0.9870 and 0.9984. The standard curves of H. incana shows a good linear approx-
imation with a R2 of 0.9960 and 0.9990.
The standard deviation of the EC50 values of H. incana shows that the results do not have
great precision. Only two experiments were performed. By performing more experiments
the precision of the assay could bee improved.
It was also found that dissolving the DPPH with magnetic stirrer did not affect the accu-
racy of the experiment, but made it easier to perform than with manual shaking.
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6 Conclusion
The rise of interest of the investigation in this thesis, is the possibility of a health benefit
of antioxidants and the possibility of isolating active compounds that may be used as lead
compounds in the development of new drugs.
The evaluation of the antioxidant capacity of the plant extract is complicated by the fact
that it is hard to compare results from different studies. Small variations in the procedures
affects the obtained results, making it difficult to compare the results.
This preliminary investigation of H. incana showed that the methanolic extract of the
plant had a moderately content of flavonoids, which are known for their antioxidant prop-
erties. All of the three in vitro assays investigating the antioxidant properties of the plant,
showed that it had a moderately antioxidant reducing capacity, even though the plant ma-
terial originated from different years. This may indicate that the various factors affecting
the plant composition, did not vary significantly in these successive years. The obtained
results suggest that H. incana have moderately antioxidant properties. The effect showed
in these in vitro experiments, can not be be extrapolated to in vivo antioxidant capacity
without further investigations.
Other important antioxidant parameters, as the ability to inhibit generation of and scav-
enge ROS/RNS, ability to chelate metals, activity as antioxidative enzymes and inhibition
of oxidative enzymes were not investigated in this thesis. Since lipophilic compounds,
as chlorophyll and carotenoids, were removed by extraction with hexane, their possible
impact on the antioxidant activity of H. incana were not measured. For a full screen-
ing of the antioxidant capacity of H. incana more assays, investigating other antioxidant
mechanisms, should be applied, and the different extract phases should also be investi-
gated.
Available literature indicates that no previous antioxidant properties studies have been
performed on H. incana, and there are also very few publications on other Herniaria
species. Since these are the first results of this kind for H. incana, they represent a
contribution to better understanding of its chemical composition, pointing the direction
for future studies.
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6.1 Further studies
The obtained results suggest a considerable content of antioxidant compounds, which
belong to the class of phenolic compounds and flavonoids. Therefore, future work should
include chemical investigation of flavonoids, as the most important antioxidants.
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D.1 Extraction of Herniaria incana
Methanolic extraction 1 (A and B):
Dry plant (g): 10,0159
Dry MeOH extract (g): 1,4876
Yield 1 (w%): 14,8523
Extraction with hexane 09.11.11 (extract A):
MeOH extract (g): 0,2213
Dry aq. Extract (g): 0,1834
Yield 2 (w%): 82,8739
Total yield (w%): 12,3087
Extraction with hexane 16.11.11 (extract B):
MeOH extract (g): 0,3212
Dry aq. Extract (g): 0,3015
Yield 2 (w%): 93,8667
Total yield (w%): 13,9414
Methanolic extraction 2 (extract C):
Dry plant (g): 9,5373
Dry MeOH extract (g): 1,38
Yield 1 (w%): 14,4695
Extraction with hexane 03.02.12 (extract C):
MeOH extract (g): 1,38
Dry aq. Extract (g): 1,1566
Yield 2 (w%): 83,8116
Total yield (w%): 12,1271
VI
D.2 Estimation of the total ﬂavonoid content
Table 8: Data of the quercetin standard curve used in the total flavonoid content assay
12.11.11
standard concentration (µg/mL) Absorbance
1 0.257 0.015
2 0.514 0.028
3 1.028 0.056
4 2.056 0.123
D.3 The Folin-Ciocalteu reagent reducing capacity assay
Table 9: Data of the gallic acid standard curve used in the Folin-Ciocalteu reducing
capacity assay 26.01.12
standard concentration (µg/mL) Absorbance
1 0.513 0.12
2 1.026 0.174
3 1.539 0.21
4 2.565 0.355
5 5.13 0.653
D.4 The phosphomolybdenum reducing capacity assay
Table 10: Data of the α-tocopherol standard curve used in the phosphomolybdenum
reducing capacity assay 21.03.12
standard concentration (µg/mL) concentration (mmol/mL) Absorbance
1 274.981 0.0006384384 0.094
2 549.963 0.0012768768 0.148
3 1099.92 0.0025537537 0.366
4 1649.89 0.0038306306 0.358
5 2199.85 0.0051075074 0.520
6 2749.81 0.0063843843 0.503
7 3574.76 0.0082996996 0.582
D.5 The DPPH free radical scavenging assay
VII
Table 11: Data from the DPPH free radical scavenging of ascorbic acid 02.04.12
Sample C (µg/mL Log C Absorbance I Probit (I)
negative control 0 - 0.487 - -
1 4.8067 0,6818 0.457 0.06160 -1.54146
2 5.4933 0.7398 0.411 0.15605 -1.01079
3 6.1800 0.7909 0.354 0.27310 -0.60346
4 7.5533 0.8781 0.202 0.58521 0.215254
Table 12: Data from the DPPH free radical scavenging of ascorbic acid 04.04.12
Sample C (µg/mL Log C Absorbance I Probit (I)
negative control 0 - 0.533 - -
1 3.15 0.4983 0.522 0.02063 -2.04074
2 4.20 0.6232 0.470 0.11819 -1.18403
3 5.25 0.7201 0.287 0.46153 -0.09655
4 6.30 0.7993 0.175 0.67166 0.444528
Table 13: Data from the DPPH free radical scavenging of ascorbic acid 06.04.12
Sample C (µg/mL Log C Absorbance I Probit (I)
negative control 0 - 0.587 - -
1 5.15 0.7118 0.545 0.07155 -1.464342
2 6.18 0.7909 0.453 0.22827 -0.744525
3 7.21 0.8579 0.290 0.50596 0.014946
4 8.24 0.9159 0.131 0.77683 0.761535
Table 14: Data from the DPPH free radical scavenging of ascorbic acid 09.04.12
Sample C (µg/mL Log C Absorbance I Probit (I)
negative control 0 - 0.559 - -
1 4.20 0.6232 0.453 0.18962 -0.87928
2 5.25 0.7201 0.289 0.48300 -0.04261
3 6.30 0.7993 0.174 0.68872 0.492253
4 7.35 0.8662 0.075 0.86583 1.106901
5 8.40 0.9242 0.035 0.93738 1.533212
Table 15: Data from the DPPH free radical scavenging of ascorbic acid 10.04.12
Sample C (µg/mL Log C Absorbance I Probit (I)
negative control 0 - 0.521 - -
1 5.25 0.7201 0.495 0.04990 -1.645784
2 6.30 0.7993 0.444 0.14779 -1.045947
3 7.35 0.8662 0.288 0.44721 -0.132696
4 8.40 0.9242 0.169 0.67562 0.4554960
VIII
Table 16: Data from the DPPH free radical scavenging of H.incana 12.04.12
Sample C (µg/mL Log C Absorbance I Probit (I)
negative control 0 - 0.555 - -
1 56.7888 1.75426 0.383 0.3099 -0.496105
2 69.6954 1.84320 0.325 0.4144 -0.216203
3 82.1410 1.91456 0.247 0.5549 0.1381902
4 94.1500 1.97382 0.203 0.6342 0.3430889
5 105.7448 2.02425 0.170 0.6936 0.5063476
6 116.9466 2.06798 0.137 0.7531 0.6844458
Table 17: Data from the DPPH free radical scavenging of H.incana 14.04.12
Sample C (µg/mL Log C Absorbance I Probit (I)
negative control 0 - 0.515 - -
1 55.5555 1.74472 0.300 0,4174 -0.208355
2 68.1818 1.83366 0.247 0.5203 0.0511282
3 80.3571 1.90502 0.198 0.6155 0.2937721
4 103.4482 2.01472 0.132 0.7436 0.6547614
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E Example of calculations
E.1 Estimation of the total ﬂavonoid content
Example of calculation of TFC (µg QUE/mg) for sample 1:
From the standard curve of quercetin (Figure 11), the equation f(x) = 0.0604x - 0.0027 is
obtained, where f(x) is the absorbance and x is the concentration of quercetin (µg/mL).
From this equation we have that:
QUE =
(Absorbance+0.0027)
0.0604
(9)
We also know that:
T FC(µg QUE/mg) =
QUE
sample concentration(mg/mL)
(10)
Put together 9 and 10 and get the expression:
T FC(µg QUE/mg) =
(Absorbance+0.0027)
0.0604
sample concentration(mg/mL)
(11)
Put in the data of sample 1 and get:
T FC(µg QUE/mg) of sample 1 =
(0.027+0.0027)
0.0604
0.024 (mg/mL)
= 20.48841(µg QUE/mg) (12)
E.2 The Folin-Ciocalteu reagent reducing capacity assay
Example of calculation of FCRC (µg GAE/mg) for sample 1:
From the standard curve of gallic acid (Figure 12, the equation f(x) = 0.1171x +0.0500 is
obtained, where f(x) is the absorbance and x is the concentration of gallic acid (µg/mL).
From this equation we have that:
GAE =
(Absorbance−0.0500)
0.1171
(13)
X
We also know that:
FCRC(µg GAE/mg) =
GAE
sample concentration(mg/mL)
(14)
Put together 13 and 14 and get the expression:
FCRC(µg GAE/mg) =
(Absorbance−0.0500)
0.1171
sample concentration(mg/mL)
(15)
Put in the data of sample 1 and get:
FCRC(µg GAE/mg) =
(0.446−0.0500)
0.1171
0.1018(mg/mL)
= 33.21930(µg GAE/mg) (16)
E.3 The phosphomolybdenum reducing capacity assay
Example of calculation of FCRC (mmol ATE/g) for sample 1:
From the standard curve of α-tocopferol (figure 13(a), the equation f(x) = 64.7671x +
0.0724 is obtained, where f(x) is the absorbance and x is the concentration of al pha-
tocopherol (mmol/mL).
From this equation we have that
ATE =
(Absorbance−0.0724)
64.7671
(17)
We also know that:
PMRC(mmol ATE/g) =
AT E
sample concentration(g/mL)
(18)
Put together 17 and 18 and get the expression:
PMRC(mmol ATE/g) =
(Absorbance−0.0724)
64.7671
sample concentration(g/mL)
(19)
XI
Put in the data of sample 1 and get:
PMRC(mmol ATE/g) =
(0.249−0.0724)
64.7671
0.0041727(mg/mL)
= 0.6535(mmol ATE/g) (20)
Example of calculation of FCRC (µg ATE/mg) for sample 1:
From the standard curve of α-tocopferol (figure 13(b), the equation f(x) = 0.00015x +
0.07236 is obtained, where f(x) is the absorbance and x is the concentration of al pha-
tocopherol (µg/mL).
From this equation we have that
ATE =
(Absorbance−0.07236)
0.00015
(21)
We also know that:
PMRC(µg ATE/mg) =
AT E
sample concentration(mg/mL)
(22)
Put together 21 and 22 and get the expression:
PMRC(µg ATE/mg) =
(Absorbance−0.07236
0.00015
sample concentration(mg/mL)
(23)
Put in the data of sample 1 and get:
PMRC(µg ATE/mg) =
(0.249−0.07236)
0.00015
4.1727(mg/mL)
= 282.2154(µg ATE/mg) (24)
E.4 The DPPH free radical scavenging assay
Example of calculation of EC50 for H. incana 12.04.12:
The data from the parallel 12.04.12 is shown in table 16.
Calculate the scavenging activity of the absorbances:
I =
Abs0−Abs1
Abs0
(25)
XII
sample 3:
I =
0.555−0.247
0.555
= 0.634234234234234 (26)
Calculate the Probit of the scavenging activity using the Norminsv function in OpenOf-
fice 3.2. Make a graph by plotting log of the concentration against the Probit of the
scavenging activity. Make a linear regression line and generate an equation Y = aX + b.
The equation Y = 3.8150x - 7.2018, was obtained. From this equation, claculate EC50.
Probit of 50 % scavenging is zero, thus the EC50 is calculated as:
EC50 = 10
−b
a (27)
The EC50 of H. incana 12.04.12 is calculated:
EC50 = 10
7.2018
3.8150 = 77.23(µg/mL) (28)
XIII
XIV
